Literature DB >> 19672875

Extent of neck dissection required after concurrent chemoradiation for stage IV head and neck squamous cell carcinoma.

Steven B Cannady1, Walter T Lee, Joseph Scharpf, Robert R Lorenz, Benjamin G Wood, Marshall Strome, Pierre Lavertu, Ramon M Esclamado, Jerrold P Saxton, David J Adelstein.   

Abstract

BACKGROUND: The management of initially bulky nodal disease after primary nonsurgical treatment for stage IV head and neck squamous cell carcinoma (HNSCC) continues to be a subject of debate.
METHODS: A retrospective chart review of neck management in patients after chemoradiation was performed.
RESULTS: Of the initially positive necks analyzed, 210/329 (65%) had a complete clinical response to treatment and 161 necks underwent neck surgery. Patients were pathologically positive 13.8% and 39.6% of the time after clinical complete or partial response, respectively. Regional recurrence was more frequent in necks with partial clinical (p = .04) or pathologic responses (p < .01) and with primary site recurrences (p < .01).
CONCLUSIONS: It is still safest at our institution to perform selective neck dissection on patients with > or = N2 neck disease when initially observed to prevent unsalvageable regional recurrence until more accurate interval assessment tools are confirmed.

Entities:  

Mesh:

Year:  2010        PMID: 19672875     DOI: 10.1002/hed.21189

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  4 in total

1.  [Follow-up ultrasound of head and neck cancer].

Authors:  J Künzel; A Bozzato; S Strieth
Journal:  HNO       Date:  2017-11       Impact factor: 1.284

Review 2.  Efficacy of neck dissection in the management of isolated nodal recurrence after head and neck cancer treatment.

Authors:  Jimmy Yu-wai Chan
Journal:  Curr Oncol Rep       Date:  2013-04       Impact factor: 5.075

Review 3.  Current philosophy in the surgical management of neck metastases for head and neck squamous cell carcinoma.

Authors:  H Hakan Coskun; Jesus E Medina; K Thomas Robbins; Carl E Silver; Primož Strojan; Afshin Teymoortash; Phillip K Pellitteri; Juan P Rodrigo; Sandro J Stoeckli; Ashok R Shaha; Carlos Suárez; Dana M Hartl; Remco de Bree; Robert P Takes; Marc Hamoir; Karen T Pitman; Alessandra Rinaldo; Alfio Ferlito
Journal:  Head Neck       Date:  2014-06-30       Impact factor: 3.147

4.  Less may be more: nodal treatment in neck positive head neck cancer patients.

Authors:  Gabriela Studer; Gerhard F Huber; Edna Holz; Christoph Glanzmann
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-04-29       Impact factor: 2.503

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.